Stephen Sanders

Array ( [id] => 4181521 [patent_doc_number] => 06159700 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Method of finding agonist and antagonist to human and rat GPR14' [patent_app_type] => 1 [patent_app_number] => 9/232857 [patent_app_country] => US [patent_app_date] => 1999-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14965 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159700.pdf [firstpage_image] =>[orig_patent_app_number] => 232857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159551 [patent_doc_number] => 20020147325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'ANTIBODIES TO RECEPTOR PROTEIN KINASES' [patent_app_type] => new [patent_app_number] => 09/223490 [patent_app_country] => US [patent_app_date] => 1998-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 30514 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147325.pdf [firstpage_image] =>[orig_patent_app_number] => 09223490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142431 [patent_doc_number] => 20020002269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-03 [patent_title] => 'ARTEMIN, A NEUROTROPHIC FACTOR' [patent_app_type] => new [patent_app_number] => 09/220920 [patent_app_country] => US [patent_app_date] => 1998-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 24105 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20020002269.pdf [firstpage_image] =>[orig_patent_app_number] => 09220920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1286734 [patent_doc_number] => 06632425 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Chemokine compositions' [patent_app_type] => B1 [patent_app_number] => 09/215160 [patent_app_country] => US [patent_app_date] => 1998-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 33 [patent_no_of_words] => 19779 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632425.pdf [firstpage_image] =>[orig_patent_app_number] => 09215160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6696320 [patent_doc_number] => 20030108514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'CHEMOKINES AS ADJUVANTS' [patent_app_type] => new [patent_app_number] => 09/212600 [patent_app_country] => US [patent_app_date] => 1998-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2657 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108514.pdf [firstpage_image] =>[orig_patent_app_number] => 09212600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1514300 [patent_doc_number] => 06420137 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Nucleic acid encoding human neurotensin subtype 2 receptor' [patent_app_type] => B1 [patent_app_number] => 09/200090 [patent_app_country] => US [patent_app_date] => 1998-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 17841 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420137.pdf [firstpage_image] =>[orig_patent_app_number] => 09200090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869985 [patent_doc_number] => 20030082674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'HUMAN PYRIMIDINE RECEPTOR' [patent_app_type] => new [patent_app_number] => 09/077173 [patent_app_country] => US [patent_app_date] => 1998-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7206 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082674.pdf [firstpage_image] =>[orig_patent_app_number] => 09077173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4285199 [patent_doc_number] => 06268157 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Method of screening for pharmaceuticals by detecting cross talk between intracellular signals and intranuclear receptors' [patent_app_type] => 1 [patent_app_number] => 9/188884 [patent_app_country] => US [patent_app_date] => 1998-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5317 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268157.pdf [firstpage_image] =>[orig_patent_app_number] => 188884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1091766 [patent_doc_number] => 06824777 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-30 [patent_title] => 'Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy' [patent_app_type] => B1 [patent_app_number] => 09/169079 [patent_app_country] => US [patent_app_date] => 1998-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 5 [patent_no_of_words] => 39050 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/824/06824777.pdf [firstpage_image] =>[orig_patent_app_number] => 09169079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4290299 [patent_doc_number] => 06268482 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Recombinant cytokine designated LERK-6' [patent_app_type] => 1 [patent_app_number] => 9/165533 [patent_app_country] => US [patent_app_date] => 1998-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13936 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268482.pdf [firstpage_image] =>[orig_patent_app_number] => 165533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736213 [patent_doc_number] => 20030013848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'PROTEIN-TYROSINE KINASE GENES' [patent_app_type] => new [patent_app_number] => 09/158722 [patent_app_country] => US [patent_app_date] => 1998-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11224 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013848.pdf [firstpage_image] =>[orig_patent_app_number] => 09158722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4154429 [patent_doc_number] => 06156523 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Serine/threonine protein kinases' [patent_app_type] => 1 [patent_app_number] => 9/153939 [patent_app_country] => US [patent_app_date] => 1998-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 24253 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156523.pdf [firstpage_image] =>[orig_patent_app_number] => 153939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1208296 [patent_doc_number] => 06713053 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Use of IL-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular' [patent_app_type] => B1 [patent_app_number] => 09/125168 [patent_app_country] => US [patent_app_date] => 1998-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4209 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713053.pdf [firstpage_image] =>[orig_patent_app_number] => 09125168 [rel_patent_id] =>[rel_patent_doc_number] =>)